Reflections from the World Parkinson Congress 2026
Date
News
Date
In this round of grants, we’ve awarded funding to 2 projects that explore new solutions to manage Parkinson’s symptoms, without the need for extra medication.
Date
A study funded by Parkinson’s UK has shown that a handheld device designed to stimulate the vagus nerve is safe and easy to use for people with Parkinson’s. However, the research found no significant improvements to symptoms.
Date
First participants receive NRG drug, further information on Herantis’ treatment and Syntara trial moves towards the data analysis phase.
Date
We achieved so much in 2025. And it’s all thanks to your support.
Date
Early results from a study of the drug developed by AC Immune offer hope that it could slow the progression of Parkinson's symptoms.
Date
A small clinical trial of a probiotic called Symprove shows it helps with non-motor symptoms of Parkinson’s, changes gut bacteria and improves efficiency of medication.
Date
A new research trial will start by testing 2 potential treatments that could slow or even stop Parkinson’s getting worse.
Date
We’ve awarded Cellestial Health £55,000 to continue exploring networks of brain cells that may hold answers for new treatments for Parkinson’s.
Date
Thanks to our crucial funding, a new drug treatment, created by NRG Therapeutics, is moving forwards.
Date
Results from 3 recent studies show that people from South Asian and Black backgrounds are less likely to receive timely access to Parkinson’s care, support and research opportunities.